|
RPA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.431200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.875000E-01 |
| Normal-vs-Stage2 |
3.495600E-01 |
| Normal-vs-Stage3 |
6.554400E-02 |
| Normal-vs-Stage4 |
2.266200E-01 |
| Stage1-vs-Stage2 |
5.667400E-01 |
| Stage1-vs-Stage3 |
3.276400E-02 |
| Stage1-vs-Stage4 |
3.334400E-01 |
| Stage2-vs-Stage3 |
3.791200E-01 |
| Stage2-vs-Stage4 |
8.413600E-01 |
| Stage3-vs-Stage4 |
4.339000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.816200E-01 |
| Normal-vs-AfricanAmerican |
1.274620E-01 |
| Normal-vs-Asian |
8.904800E-01 |
| Caucasian-vs-AfricanAmerican |
3.164800E-01 |
| Caucasian-vs-Asian |
7.485600E-01 |
| AfricanAmerican-vs-Asian |
5.185600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.133200E-01 |
| Normal-vs-Female |
8.684100E-02 |
| Male-vs-Female |
5.680400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.137800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.880200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.608000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.185700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.264600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.878000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.894600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.248000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.932190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.407200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.647400E-01 |
| Normal-vs-Grade 2 |
9.653600E-01 |
| Normal-vs-Grade 3 |
1.023190E-01 |
| Normal-vs-Grade 4 |
2.363800E-02 |
| Grade 1-vs-Grade 2 |
8.936200E-01 |
| Grade 1-vs-Grade 3 |
3.558600E-01 |
| Grade 1-vs-Grade 4 |
1.429180E-01 |
| Grade 2-vs-Grade 3 |
2.236200E-03 |
| Grade 2-vs-Grade 4 |
4.042300E-04 |
| Grade 3-vs-Grade 4 |
2.176200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.600400E-01 |
| Normal-vs-ccB subtype |
1.660180E-02 |
| ccA subtype-vs-ccB subtype |
4.81169999955178E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.466600E-01 |
| Normal-vs-N1 |
4.281600E-01 |
| N0-vs-N1 |
7.512600E-01 |
|
|
